Invention Grant
- Patent Title: Remnant tumor infiltrating lymphocytes and methods of preparing and using the same
-
Application No.: US17141454Application Date: 2021-01-05
-
Publication No.: US11293009B2Publication Date: 2022-04-05
- Inventor: Michelle R. Simpson-Abelson , Christopher Mosychuk , Michael T. Lotze
- Applicant: Iovance Biotherapeutics, Inc.
- Applicant Address: US CA San Carlos
- Assignee: Iovance Biotherapeutics, Inc.
- Current Assignee: Iovance Biotherapeutics, Inc.
- Current Assignee Address: US CA San Carlos
- Agency: Morgan, Lewis & Bockius LLP
- Main IPC: C12N5/0783
- IPC: C12N5/0783 ; A61P35/00 ; A61K31/661 ; A61K35/17 ; A61K38/20 ; A61K39/00
Abstract:
In some embodiments, methods of delivering a therapeutically effective amount of an expanded number of tumor infiltrating lymphocytes obtained from tumor remnants to a patient in need thereof, for the treatment of a cancer, are disclosed.
Public/Granted literature
- US20210123020A1 Remnant Tumor Infiltrating Lymphocytes and Methods of Preparing and Using the Same Public/Granted day:2021-04-29
Information query
